Cargando…
Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408970/ https://www.ncbi.nlm.nih.gov/pubmed/27765808 http://dx.doi.org/10.1093/ijnp/pyw089 |
_version_ | 1783232391105478656 |
---|---|
author | Dong, Chao Zhang, Ji-chun Yao, Wei Ren, Qian Ma, Min Yang, Chun Chaki, Shigeyuki Hashimoto, Kenji |
author_facet | Dong, Chao Zhang, Ji-chun Yao, Wei Ren, Qian Ma, Min Yang, Chun Chaki, Shigeyuki Hashimoto, Kenji |
author_sort | Dong, Chao |
collection | PubMed |
description | BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the effects of MGS0039 (1 mg/kg) and ketamine (10 mg/kg) on depression-like behavior in susceptible mice after repeated social defeat stress. Protein levels of brain-derived neurotrophic factor, TrkB, phospho-TrkB, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (GluA1), postsynaptic density protein 95, and dendritic spine density in selected brain regions were measured. RESULTS: In the tail suspension and forced swimming tests, both MGS0039 and ketamine significantly attenuated the increased immobility time observed in susceptible mice, compared with vehicle-treated animals, 1 or 2 days after a single dose of drug. In the sucrose preference test, both compounds significantly improved the reduced preference typically seen in susceptible mice at 3 to 7 days after a single dose of drug. Western-blot analyses showed that similar to ketamine, MGS0039 significantly attenuated the reduced brain-derived neurotrophic factor, phospho-TrkB/TrkB ratio, GluA1 and postsynaptic density protein 95 seen in the prefrontal cortex, dentate gyrus, and CA3 of the hippocampus from susceptible mice, 8 days after a single dose. Again, in a similar manner to ketamine, MGS0039 significantly attenuated the reduction of spine density in the prelimbic regions of the medial prefrontal cortex, dentate gyrus, and CA3 of the hippocampus, but not infralimbic regions of the medial prefrontal cortex and CA1, in susceptible mice 8 days after a single dose. In contrast, neither drug elicited an effect on altered brain-derived neurotrophic factor-TrkB signaling, GluA1, and postsynaptic density protein 95 levels and did not increase spine density observed in the nucleus accumbens of susceptible mice. CONCLUSIONS: Similar to ketamine, MGS0039 shows rapid and sustained antidepressant effects in the social defeat stress model. Long-lasting synaptogenesis in the prelimbic regions of medial prefrontal cortex, dentate gyrus, and CA3 might be implicated in this sustained antidepressant effect. |
format | Online Article Text |
id | pubmed-5408970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54089702017-05-03 Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine Dong, Chao Zhang, Ji-chun Yao, Wei Ren, Qian Ma, Min Yang, Chun Chaki, Shigeyuki Hashimoto, Kenji Int J Neuropsychopharmacol Regular Research Article BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the effects of MGS0039 (1 mg/kg) and ketamine (10 mg/kg) on depression-like behavior in susceptible mice after repeated social defeat stress. Protein levels of brain-derived neurotrophic factor, TrkB, phospho-TrkB, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (GluA1), postsynaptic density protein 95, and dendritic spine density in selected brain regions were measured. RESULTS: In the tail suspension and forced swimming tests, both MGS0039 and ketamine significantly attenuated the increased immobility time observed in susceptible mice, compared with vehicle-treated animals, 1 or 2 days after a single dose of drug. In the sucrose preference test, both compounds significantly improved the reduced preference typically seen in susceptible mice at 3 to 7 days after a single dose of drug. Western-blot analyses showed that similar to ketamine, MGS0039 significantly attenuated the reduced brain-derived neurotrophic factor, phospho-TrkB/TrkB ratio, GluA1 and postsynaptic density protein 95 seen in the prefrontal cortex, dentate gyrus, and CA3 of the hippocampus from susceptible mice, 8 days after a single dose. Again, in a similar manner to ketamine, MGS0039 significantly attenuated the reduction of spine density in the prelimbic regions of the medial prefrontal cortex, dentate gyrus, and CA3 of the hippocampus, but not infralimbic regions of the medial prefrontal cortex and CA1, in susceptible mice 8 days after a single dose. In contrast, neither drug elicited an effect on altered brain-derived neurotrophic factor-TrkB signaling, GluA1, and postsynaptic density protein 95 levels and did not increase spine density observed in the nucleus accumbens of susceptible mice. CONCLUSIONS: Similar to ketamine, MGS0039 shows rapid and sustained antidepressant effects in the social defeat stress model. Long-lasting synaptogenesis in the prelimbic regions of medial prefrontal cortex, dentate gyrus, and CA3 might be implicated in this sustained antidepressant effect. Oxford University Press 2016-10-08 /pmc/articles/PMC5408970/ /pubmed/27765808 http://dx.doi.org/10.1093/ijnp/pyw089 Text en © The Author 2016. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Regular Research Article Dong, Chao Zhang, Ji-chun Yao, Wei Ren, Qian Ma, Min Yang, Chun Chaki, Shigeyuki Hashimoto, Kenji Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title_full | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title_fullStr | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title_full_unstemmed | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title_short | Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine |
title_sort | rapid and sustained antidepressant action of the mglu2/3 receptor antagonist mgs0039 in the social defeat stress model: comparison with ketamine |
topic | Regular Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408970/ https://www.ncbi.nlm.nih.gov/pubmed/27765808 http://dx.doi.org/10.1093/ijnp/pyw089 |
work_keys_str_mv | AT dongchao rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT zhangjichun rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT yaowei rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT renqian rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT mamin rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT yangchun rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT chakishigeyuki rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine AT hashimotokenji rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine |